Sun Pharmaceutical Industries Ltd

  • BSE Code : 524715
  • NSE Symbol : SUNPHARMA
  • ISIN : INE044A01036
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,677.60 -22.20(-1.31%)

Open Price ()

1,702.00

Prev. Close ()

1,699.80

Volume (No’s)

3,640,641

Market Cap ()

402,512.43

Low Price ()

1,669.10

High Price ()

1,713.60

 

Profit and Loss

 Mar 2024 (.Cr) Mar 2023 (.Cr) Mar 2022 (.Cr) Mar 2021 (.Cr) Mar 2020 (.Cr) Mar 2019 (.Cr)
INCOME :      
Sales Turnover 20,275.1720,812.1415,585.9814,116.0512,531.9310,303.21
Excise Duty0.000.000.000.000.000.00
Net Sales20,275.1720,812.1415,585.9814,116.0512,531.9310,303.21
Other Income 553.48329.291,196.88192.071,510.921,271.44
Stock Adjustments -180.32237.93183.18179.64-138.60251.30
Total Income20,648.3321,379.3616,966.0414,487.7613,904.2511,825.95
EXPENDITURE :      
Raw Materials 5,423.796,292.095,833.575,287.124,429.123,924.56
Power & Fuel Cost450.42495.21422.33384.16394.74407.28
Employee Cost 2,373.952,156.952,000.781,805.981,702.771,571.34
Other Manufacturing Expenses 1,195.301,037.321,064.32862.12860.05898.51
Selling & Administrative Expenses 4,754.864,326.423,514.053,309.621,919.251,503.17
Miscellaneous Expenses 615.663,257.272,086.08479.24375.751,707.77
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure14,813.9817,565.2614,921.1312,128.249,681.6810,012.63
Operating Profit5,834.353,814.102,044.912,359.524,222.571,813.32
Interest 784.08472.18388.10267.52408.01540.92
Gross Profit5,050.273,341.921,656.812,092.003,814.561,272.40
Depreciation1,600.621,600.871,349.951,236.43561.56552.95
Profit Before Tax3,449.651,741.05306.86855.573,253.00719.45
Tax546.10752.77-553.58244.91386.461.55
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax45.37-702.44960.43-231.74-344.60-98.70
Reported Net Profit2,858.181,690.72-99.99842.403,211.14816.60
Extraordinary Items -193.46-1,665.671,237.51-63.64193.27-1,048.68
Adjusted Net Profit3,051.643,356.39-1,337.50906.043,017.871,865.28
Adjustment below Net Profit -19.867.38-14.532,675.94-211.5210.17
P & L Balance brought forward12,790.8813,612.0815,964.5514,005.2712,384.6112,037.00
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 2,898.162,519.302,237.951,559.061,378.96479.16
P & L Balance carried down12,731.0412,790.8813,612.0815,964.5514,005.2712,384.61
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1,350.001,150.001,000.00750.00400.00275.00
Dividend Per Share(Rs)13.5011.5010.007.504.002.75
Earnings Per Share-Unit Curr11.917.05-0.423.5113.383.40
Earnings Per Share(Adj)-Unit Curr11.917.05-0.423.5113.383.40
Book Value-Unit Curr98.7698.98102.48112.28101.6895.21
Book Value(Adj)-Unit Curr98.7698.98102.48112.28101.6895.21

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew